Editorial
Cytomics in predictive medicine
Article first published online: 21 APR 2003
DOI: 10.1002/cyto.b.10035
Copyright © 2003 Wiley-Liss, Inc.
Issue
1552-4957/asset/cover.gif?v=1&s=e900cf7c0d68ffcbb0296a0431aaec549f9a9bb8 "Cytometry Part B: Clinical Cytometry")
Cytometry Part B: Clinical Cytometry
Special Issue: Cytomics in Predictive Medicine
Volume 53B, Issue 1, pages 1–3, May 2003
Additional Information
How to Cite
Valet, G. K. and Tárnok, A. (2003), Cytomics in predictive medicine. Cytometry, 53B: 1–3. doi: 10.1002/cyto.b.10035
Publication History
- Issue published online: 21 APR 2003
- Article first published online: 21 APR 2003
- Manuscript Accepted: 26 FEB 2003
- Manuscript Received: 14 JAN 2003
- Abstract
- Article
- References
- Cited By
Keywords:
- predictive medicine;
- clinical cytomics;
- medical bioinformatics
Abstract
Patient-specific, disease-course predictions with >95% or >99% accuracy during therapy would be highly valuable for everyday medicine. If these predictors were available, disease aggravation or progression, frequently accompanied by irreversible tissue damage or therapeutic side effects, could then potentially be avoided by early preventive therapy. The molecular analysis of heterogeneous cellular systems (cytomics) by cytometry in conjunction with pattern-oriented bioinformatic analysis of the multiparametric cytometric and other data provides a promising approach to individualized or personalized medical treatment or disease management. As a consequence, better patient care and new forms of inductive scientific hypothesis development based on the interpretation of predictive data patterns are at reach. Cytometry Part B (Clin. Cytometry) 53B:1–3, 2003. © 2003 Wiley-Liss, Inc.